Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19

Gunawan, Alyssa Claudia V. and Novita, Bernadette Dian (2020) Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19. Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19, 6 (2). pp. 103-110. ISSN pISSN: 2338-0373, eISSN: 2623-2723, Jurnal Nasional Terakreditasi Sinta 4

[thumbnail of Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19] Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19)
11-Hyper-coagulation_and_.pdf

Download (886kB)
[thumbnail of Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19] Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19)
10-Hyper-coagulation_and_Hasil Cek Similarity.pdf

Download (1MB)
[thumbnail of Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19_peer_review_] Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19_peer_review_)
9-R1&2-Hyper-coagulation_and_the_.pdf

Download (1MB)

Abstract

Coronavirus SARS-CoV-2 (COVID-19) infection has become a global infection with high mortality and morbidity rate. The pathophysiology of COVID-19 has not yet clear but associated with increasing proinflammatory cytokines and chemokines that leads to cytokine storm. Cytokine storm leads to increasing coagulation that defined by increasing D-dimer, Prothrombin Time (PT), and activated partial thromboplastin time (aPTT). The use of anticoagulant in patient with COVID-19 decrease the mortality rate and become one of the recommended therapy.

Item Type: Article
Additional Information: Jurnal Nasional Terakreditasi Sinta 4
Uncontrolled Keywords: COVID-19, Hyper-coagulation, Anticoagulant
Subjects: Medicine
Divisions: Journal Publication
Depositing User: F.X. Hadi
Date Deposited: 02 Nov 2021 05:28
Last Modified: 12 Jan 2022 02:45
URI: http://repository.ukwms.ac.id/id/eprint/27275

Actions (login required)

View Item View Item